We are live on ! Find out more
VIVS

VivoSim Labs

116 hedge funds and large institutions have $50.2M invested in VivoSim Labs in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

62% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 21

5% more funds holding

Funds holding: 110116 (+6)

0.01% more ownership

Funds ownership: 0.14%0.15% (+0.01%)

10% less capital invested

Capital invested by funds: $55.6M → $50.2M (-$5.36M)

73% less call options, than puts

Call options by funds: $36K | Put options by funds: $131K

Holders
116
Holders Change
+6
Holders Change %
+5.45%
% of All Funds
2.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
34
Reduced
21
Closed
9
Calls
$36K
Puts
$131K
Net Calls
-$95K
Net Calls Change
-$82K
Name Holding Trade Value Shares
Change
Change in
Stake
AIM
1
ARK Investment Management
Florida
$20.6M +$3.87M +12,878 +21%
BlackRock
2
BlackRock
New York
$8.13M +$128K +427 +1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$5.49M +$65K +216 +1%
CWM
4
Cornerstone Wealth Management
Missouri
$1.89M +$601 +2 +15%
State Street
5
State Street
Massachusetts
$1.88M +$44.8K +149 +2%
Renaissance Technologies
6
Renaissance Technologies
New York
$1.79M +$396K +1,318 +25%
Northern Trust
7
Northern Trust
Illinois
$1.51M +$197K +654 +14%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$1.45M +$82.4K +274 +5%
UBS Group
9
UBS Group
Switzerland
$1.03M -$601 -2 -0.1%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$398K -$10.5K -35 -2%
Morgan Stanley
11
Morgan Stanley
New York
$358K -$51.4K -171 -12%
Deutsche Bank
12
Deutsche Bank
Germany
$334K +$74.9K +249 +26%
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$333K +$19.2K +64 +6%
BCM
14
Bridgeway Capital Management
Texas
$315K
PM
15
Penbrook Management
New York
$310K
AFG
16
American Financial Group
Ohio
$289K
Charles Schwab
17
Charles Schwab
California
$271K -$293K -973 -50%
LFR
18
Lehman Financial Resources
Pennsylvania
$245K +$37.9K +126 +16%
TCIM
19
TIAA CREF Investment Management
New York
$228K -$12.9K -43 -5%
TA
20
Teachers Advisors
New York
$212K -$2.41K -8 -1%
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$198K +$16.2K +54 +8%
SPC
22
Sigma Planning Corp
Michigan
$144K
LPL Financial
23
LPL Financial
California
$142K +$7.52K +25 +5%
Citadel Advisors
24
Citadel Advisors
Florida
$142K +$119K +395 +332%
JMPWA
25
JP Morgan Private Wealth Advisors
California
$133K

VIVS Hedge Fund Activity: Q3 2018 in Review

116 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q3 2018, worth a combined $50.2M — down 9.6% from $55.6M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new VIVS positions and 9 closed out — a net gain of 6 holders — while 34 added to existing stakes and 21 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $3.87M. The largest seller was Charles Schwab, cutting an estimated $293K.

  • 116 institutional investors held VivoSim Labs (VIVS) as of Q3 2018, up from 110 in Q2 2018.
  • Funds reported $50.2M of VivoSim Labs stock for Q3 2018, down 9.6% quarter-over-quarter.
  • 15 funds opened new VivoSim Labs positions in Q3 2018 and 9 closed out, a net change of +6 holders.
  • The largest VivoSim Labs buyer in Q3 2018 was ARK Investment Management, an estimated $3.87M added.
  • The largest VivoSim Labs seller in Q3 2018 was Charles Schwab, an estimated $293K sold.

Based on aggregated 13F filings for Q3 2018.